| Noncolorectal Gastrointestinal Cancer |
1 |
0.97 |
| Chemotherapy |
0 |
0.74 |
| Combination Chemotherapy |
0 |
0.55 |
| Gastric Cancer |
0 |
0.42 |
| Toxicology |
0 |
0.42 |
| Adenocarcinoma |
0 |
0.34 |
| Cancer |
0 |
0.34 |
| Adenocarcinoma of the Gastroesophageal Junction |
0 |
0.3 |
| Perioperative Care |
0 |
0.3 |
| Biologic Therapy |
0 |
0.27 |
| Esophageal Adenocarcinoma |
0 |
0.26 |
| Genomic Medicine |
0 |
0.23 |
| Scan |
0 |
0.11 |
| Epidermal Growth Factor Receptor |
0 |
0.08 |
| Calcium |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Diarrhea |
0 |
0.07 |
| Gastroenteritis |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Neoadjuvant Therapy |
0 |
0.07 |
| Osteoarthritis |
0 |
0.07 |
| Platinum |
0 |
0.07 |
| Receptors |
0 |
0.07 |
| Spine |
0 |
0.07 |
| Tyrosine Kinase Inhibitor |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Hypertension |
0 |
0.04 |
| Preoperative |
0 |
0.04 |
| Prognosis |
0 |
0.04 |
| Taxane |
0 |
0.04 |
| Tumor |
0 |
0.04 |
| Tyrosine Kinase |
0 |
0.04 |
| Vascular Endothelial Growth Factor |
0 |
0.04 |